FLEXION THERAPEUTICS INC's ticker is FLXN and the CUSIP is 33938J106. A total of 86 filers reported holding FLEXION THERAPEUTICS INC in Q3 2016. The put-call ratio across all filers is 0.43 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $120,000 | -8.4% | 14,725 | -7.5% | 0.00% | – |
| Q2 2021 | $131,000 | -27.2% | 15,925 | -20.9% | 0.00% | – |
| Q1 2021 | $180,000 | +10.4% | 20,140 | +42.2% | 0.00% | – |
| Q4 2020 | $163,000 | +181.0% | 14,164 | +150.0% | 0.00% | – |
| Q3 2020 | $58,000 | +16.0% | 5,665 | -11.8% | 0.00% | – |
| Q1 2020 | $50,000 | -95.5% | 6,426 | -88.0% | 0.00% | -100.0% |
| Q4 2019 | $1,112,000 | +1363.2% | 53,745 | +865.1% | 0.00% | – |
| Q3 2019 | $76,000 | -39.2% | 5,569 | -45.6% | 0.00% | – |
| Q2 2019 | $125,000 | -57.5% | 10,237 | -56.6% | 0.00% | -100.0% |
| Q1 2019 | $294,000 | +62.4% | 23,589 | +153.7% | 0.00% | -91.7% |
| Q3 2016 | $181,000 | +2916.7% | 9,297 | +2178.7% | 0.01% | – |
| Q2 2016 | $6,000 | -92.0% | 408 | -89.6% | 0.00% | -100.0% |
| Q4 2015 | $75,000 | +294.7% | 3,909 | +190.6% | 0.01% | +500.0% |
| Q3 2015 | $19,000 | – | 1,345 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Novo Holdings A/S | 1,500,000 | $36,270,000 | 4.72% |
| Gagnon Advisors, LLC | 108,498 | $2,623,000 | 1.99% |
| NEXTHERA CAPITAL LP | 271,136 | $6,556,000 | 1.69% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 883,321 | $21,359,000 | 1.39% |
| GILDER GAGNON HOWE & CO LLC | 3,961,647 | $95,793,000 | 1.35% |
| GAGNON SECURITIES LLC | 144,331 | $3,490,000 | 1.30% |
| MILLER VALUE PARTNERS, LLC | 1,181,325 | $28,564,000 | 1.23% |
| SCHOLTZ & COMPANY, LLC | 55,250 | $1,336,000 | 1.05% |
| ARDSLEY ADVISORY PARTNERS LP | 175,000 | $4,232,000 | 0.56% |
| Ratan Capital Management LP | 32,077 | $776,000 | 0.47% |